Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

Hong Kong Med J. 2023 Aug;29 Suppl 4(4):18-21.

M K Kwok¹, G M Leung¹, L Xu², H F Tse³, T H Lam¹, T H So⁴, C M Schooling^{1

5}

¹ School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
² School of Public Health, Sun Yat-sen University, Guangzhou, China.
³ Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁴ Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁵ City University of New York Graduate School of Public Health and Health Policy, New York, NY, United States.

No abstract available

Publication types